tetrahydrocurcumin has been researched along with Hepatocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Changtam, C; Patumraj, S; Suksamrarn, A; Wirachwong, P; Yoysungnoen, P | 1 |
1 other study(ies) available for tetrahydrocurcumin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Curcumin; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation | 2008 |